Rxsight Total Assets from 2010 to 2024

RXST Stock

USD 45.05 0.24 0.54%

Rxsight Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 162 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

182.6 M

Current Value

162 M

Quarterly Volatility

30 M

Credit Downgrade

Yuan Drop

Covid

Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.

Check out the analysis of Rxsight Correlation against competitors.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Latest Rxsight's Total Assets Growth Pattern

Below is the plot of the Total Assets of Rxsight over the last few years. Total assets refers to the total amount of Rxsight assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rxsight books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Rxsight's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 182.55 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Rxsight Total Assets Regression Statistics

	Arithmetic Mean	126,164,779
	Geometric Mean	123,336,565
	Coefficient Of Variation	23.78
	Mean Deviation	24,375,409
	Median	110,432,000
	Standard Deviation	29,996,220
	Sample Variance	899.8T
	Range	92M
	R-Value	0.69
	Mean Square Error	510T
	R-Squared	0.47
	Significance	0
	Slope	4,616,117
	Total Sum of Squares	12596.8T

Rxsight Total Assets History

	2024	162 M
	2023	182.6 M
	2022	150.2 M
	2021	192.7 M
	2020	100.7 M

Other Fundumenentals of Rxsight

Intangibles To Total Assets

Rxsight Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Capital Surpluse
Total Assets		0.96	0.96	0.76	0.31	-0.81	0.46	0.77	0.98	-0.95	0.96	1.0	-0.95	1.0	0.77	-0.95	-0.94	0.98	-0.54	0.67
Total Stockholder Equity	0.96		1.0	0.83	0.37	-0.92	0.47	0.88	0.91	-1.0	1.0	0.96	-0.97	0.94	0.85	-0.97	-0.98	0.99	-0.66	0.73
Net Tangible Assets	0.96	1.0		0.81	0.42	-0.9	0.45	0.85	0.91	-1.0	1.0	0.96	-0.98	0.95	0.88	-0.98	-0.99	0.99	-0.61	0.69
Current Deferred Revenue	0.76	0.83	0.81		0.18	-0.88	0.78	0.89	0.66	-0.84	0.81	0.77	-0.8	0.72	0.61	-0.8	-0.88	0.86	-0.6	0.9
Net Debt	0.31	0.37	0.42	0.18		-0.16	-0.33	0.06	0.25	-0.4	0.43	0.33	-0.32	0.32	0.76	-0.32	-0.44	0.38	0.29	-0.19
Retained Earnings	-0.81	-0.92	-0.9	-0.88	-0.16		-0.6	-0.99	-0.72	0.93	-0.91	-0.81	0.88	-0.77	-0.7	0.88	0.9	-0.88	0.85	-0.88
Accounts Payable	0.46	0.47	0.45	0.78	-0.33	-0.6		0.64	0.44	-0.48	0.43	0.47	-0.56	0.43	0.17	-0.56	-0.52	0.52	-0.49	0.8
Net Receivables	0.77	0.88	0.85	0.89	0.06	-0.99	0.64		0.67	-0.88	0.86	0.77	-0.82	0.72	0.61	-0.82	-0.86	0.85	-0.88	0.93
Short Term Investments	0.98	0.91	0.91	0.66	0.25	-0.72	0.44	0.67		-0.89	0.9	0.98	-0.92	0.99	0.72	-0.92	-0.87	0.93	-0.48	0.59
Total Liab	-0.95	-1.0	-1.0	-0.84	-0.4	0.93	-0.48	-0.88	-0.89		-1.0	-0.95	0.97	-0.93	-0.86	0.97	0.99	-0.99	0.65	-0.73
Net Invested Capital	0.96	1.0	1.0	0.81	0.43	-0.91	0.43	0.86	0.9	-1.0		0.96	-0.96	0.94	0.88	-0.96	-0.99	0.99	-0.62	0.7
Total Current Assets	1.0	0.96	0.96	0.77	0.33	-0.81	0.47	0.77	0.98	-0.95	0.96		-0.95	1.0	0.78	-0.95	-0.95	0.98	-0.54	0.68
Capital Stock	-0.95	-0.97	-0.98	-0.8	-0.32	0.88	-0.56	-0.82	-0.92	0.97	-0.96	-0.95		-0.93	-0.85	1.0	0.95	-0.96	0.6	-0.68
Net Working Capital	1.0	0.94	0.95	0.72	0.32	-0.77	0.43	0.72	0.99	-0.93	0.94	1.0	-0.93		0.76	-0.93	-0.92	0.96	-0.51	0.63
Short Term Debt	0.77	0.85	0.88	0.61	0.76	-0.7	0.17	0.61	0.72	-0.86	0.88	0.78	-0.85	0.76		-0.85	-0.87	0.83	-0.3	0.34
Common Stock	-0.95	-0.97	-0.98	-0.8	-0.32	0.88	-0.56	-0.82	-0.92	0.97	-0.96	-0.95	1.0	-0.93	-0.85		0.95	-0.96	0.6	-0.68
Property Plant Equipment	-0.94	-0.98	-0.99	-0.88	-0.44	0.9	-0.52	-0.86	-0.87	0.99	-0.99	-0.95	0.95	-0.92	-0.87	0.95		-0.99	0.57	-0.74
Long Term Debt	0.98	0.99	0.99	0.86	0.38	-0.88	0.52	0.85	0.93	-0.99	0.99	0.98	-0.96	0.96	0.83	-0.96	-0.99		-0.58	0.74
Long Term Debt Total	-0.54	-0.66	-0.61	-0.6	0.29	0.85	-0.49	-0.88	-0.48	0.65	-0.62	-0.54	0.6	-0.51	-0.3	0.6	0.57	-0.58		-0.83
Capital Surpluse	0.67	0.73	0.69	0.9	-0.19	-0.88	0.8	0.93	0.59	-0.73	0.7	0.68	-0.68	0.63	0.34	-0.68	-0.74	0.74	-0.83

Click cells to compare fundamentals

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	182.6 M	162 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC